• Office of Research and Technology Ventures

    Dana-Farber and Astellas Pharma Inc. have entered into a three-year collaboration to research and develop small molecule inhibitors of oncogenic
    K-Ras for the treatment of cancer, including lung cancer.

    read more ›  
     

    The Joint Center for Cancer Precision Medicine has been established to create "precision medicine treatment pathways" for patients with advanced cancers and to speed the development of personalized therapies.

    read more ›  
    Levi Garraway
     

    The human immune system is capable of recognizing cancer cells, but it doesn't effectively kill them: Dana-Farber discoveries show why this is so, and how drugs can be developed to overcome this immune suppression.

    read more ›  
     

    Dana-Farber and its Belfer Institute for Applied Cancer Science have entered into a new collaboration with Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc., to investigate immunotherapy approaches for lung cancer.

    read more ›